Document is current
Any future updates will be listed below
-
Authors
Taubman, Danielle S.
Parikh, Sagar V.
- License Information
-
More Information
Article History
Accepted: 25 July 2023
First Online: 17 August 2023
Declarations
:
: Danielle S. Taubman declares no potential conflicts of interest. Sagar V. Parikh has received consultancy fees from SAGE pharma, Jannsen, Takeda, Myriad, and Neonmind; grants from Merck, Sage, and Janssen; honorarium from Otsuka; and owns Neonmind stock.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
